PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 62 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $175,000 | -14.2% | 18,000 | -10.0% | 0.42% | -5.4% |
| Q2 2018 | $204,000 | -21.5% | 20,000 | 0.0% | 0.44% | -13.3% |
| Q1 2018 | $260,000 | -63.7% | 20,000 | -50.0% | 0.51% | -17.6% |
| Q4 2017 | $716,000 | -28.7% | 40,000 | 0.0% | 0.62% | -31.3% |
| Q3 2017 | $1,004,000 | +4.1% | 40,000 | 0.0% | 0.90% | +2.0% |
| Q2 2017 | $964,000 | -37.4% | 40,000 | -50.0% | 0.88% | -22.7% |
| Q1 2017 | $1,540,000 | +25.0% | 80,000 | 0.0% | 1.14% | +16.5% |
| Q4 2016 | $1,232,000 | +18.3% | 80,000 | 0.0% | 0.98% | +68.0% |
| Q3 2016 | $1,041,000 | +98.7% | 80,000 | +112.4% | 0.58% | +15.4% |
| Q2 2016 | $524,000 | -23.3% | 37,665 | -16.3% | 0.51% | -4.2% |
| Q1 2016 | $683,000 | -40.0% | 45,000 | -25.0% | 0.53% | -29.8% |
| Q4 2015 | $1,138,000 | – | 60,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $40,639,000 | 22.88% |
| Abingworth LLP | 1,301,413 | $24,701,000 | 14.43% |
| Roumell Asset Management, LLC | 201,845 | $3,835,000 | 7.78% |
| GREAT POINT PARTNERS LLC | 453,878 | $8,624,000 | 3.41% |
| Aisling Capital LLC | 682,680 | $12,971,000 | 2.28% |
| Broadfin Capital, LLC | 530,283 | $10,075,000 | 0.56% |
| Tekla Capital Management LLC | 762,581 | $14,489,000 | 0.52% |
| Baupost Group | 1,544,498 | $29,345,000 | 0.49% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $5,264,000 | 0.47% |
| Lombard Odier Asset Management (USA) Corp | 135,710 | $2,578,000 | 0.22% |